1. “Open Sesame?”: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer
   Ornella Randazzo et al, 2020, Cancers CrossRef
2. Synthesis and Biological Evaluation of Sclareolide-Indole Conjugates and Their Derivatives
   Ying Cheng et al, 2023, Molecules CrossRef
3. Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
   Wenhao Luo et al, 2019, Cancer Medicine CrossRef
4. Efficient Biotransformation of Sclareol to Sclareolide by Filobasidium magnum JD1025
   Yakun Fang et al, 2023, Applied Biochemistry and Biotechnology CrossRef
5. Targeted therapies in pancreatic cancer: Promises and failures
   Matineh Barati Bagherabad et al, 2019, Journal of Cellular Biochemistry CrossRef
6. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
   Milad Ashrafizadeh et al, 2024, Environmental Research CrossRef
7. Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer
   Laura Cecilia Laurella et al, 2022, Molecules CrossRef
8. Discovery of sclareol and sclareolide as filovirus entry inhibitors
   Qing Chen et al, 2020, Journal of Asian Natural Products Research CrossRef